Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Yu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 12, 2025
Temporal Rule Mining for Enhanced Risk Pattern Extraction: A Case Study with Acute Kidney InjuryHo Yin Chan, Alan S Yu, Mei Liu
American Journal of Physiology. Cell Physiology|November 2, 2012
Effects of ACE inhibition and ANG II stimulation on renal Na-Cl cotransporter distribution, phosphorylation, and membrane complex propertiesDonna H Lee, Arvid B Maunsbach, Anne D Riquier-Brison, et al.
American Journal of Physiology. Cell Physiology|August 19, 2007
Transepithelial bioelectrical properties of rabbit acinar cell monolayers on polyester membrane scaffoldsShivaram Selvam, Padmaja B Thomas, Hovhannes J Gukasyan, et al.
The Journal of Clinical Investigation|October 10, 2023
Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healingRizwan Ahmad, Balawant Kumar, Ishwor Thapa, et al.
Journal of the American Society of Nephrology : JASN|August 1, 2015
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis BurdenJason R Stubbs, John A House, A Jacob Ocque, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 4, 2018
The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 MutationsEmilie Cornec-Le Gall, Fouad T Chebib, Charles D Madsen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2016
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trialMaría V Irazabal, Kaleab Z Abebe, Kyongtae Ty Bae, et al.
Kidney360|July 29, 2021
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKDCassandra Kimber, Shiqin Zhang, Cassandra Johnson, et al.
Kidney International|December 21, 2016
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Robert W Schrier, et al.
American Journal of Human Genetics|May 1, 2018
Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney DiseaseEmilie Cornec-Le Gall, Rory J Olson, Whitney Besse, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 12, 2025
Temporal Rule Mining for Enhanced Risk Pattern Extraction: A Case Study with Acute Kidney InjuryHo Yin Chan, Alan S Yu, Mei Liu
American Journal of Physiology. Cell Physiology|November 2, 2012
Effects of ACE inhibition and ANG II stimulation on renal Na-Cl cotransporter distribution, phosphorylation, and membrane complex propertiesDonna H Lee, Arvid B Maunsbach, Anne D Riquier-Brison, et al.
American Journal of Physiology. Cell Physiology|August 19, 2007
Transepithelial bioelectrical properties of rabbit acinar cell monolayers on polyester membrane scaffoldsShivaram Selvam, Padmaja B Thomas, Hovhannes J Gukasyan, et al.
The Journal of Clinical Investigation|October 10, 2023
Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healingRizwan Ahmad, Balawant Kumar, Ishwor Thapa, et al.
Journal of the American Society of Nephrology : JASN|August 1, 2015
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis BurdenJason R Stubbs, John A House, A Jacob Ocque, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 4, 2018
The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 MutationsEmilie Cornec-Le Gall, Fouad T Chebib, Charles D Madsen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2016
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trialMaría V Irazabal, Kaleab Z Abebe, Kyongtae Ty Bae, et al.
Kidney360|July 29, 2021
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKDCassandra Kimber, Shiqin Zhang, Cassandra Johnson, et al.
Kidney International|December 21, 2016
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Robert W Schrier, et al.
American Journal of Human Genetics|May 1, 2018
Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney DiseaseEmilie Cornec-Le Gall, Rory J Olson, Whitney Besse, et al.
Pageof 1